Advances of long non-coding RNAs in osteoclast differentiation and osteoporosis

被引:2
作者
Liu, Wenjie [1 ,3 ]
Zhang, Yunhui [1 ]
Li, Quanfeng [1 ,3 ]
Wang, Xinglang [1 ,3 ]
Wu, Yanfeng [2 ,3 ]
Shen, Huiyong [1 ,3 ]
Wang, Peng [1 ,3 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Orthoped, 3025 Shennan Middle Rd, Shenzhen 518033, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 8, Ctr Biotherapy, Shenzhen 518033, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 8, Guangdong Prov Clin Res Ctr Orthoped Dis, Shenzhen 518033, Peoples R China
关键词
Osteoclasts; Osteoporosis; LncRNA; Treatment; MESENCHYMAL STEM-CELLS; LNCRNA-ANCR PROMOTES; NOTCH SIGNALING PATHWAY; AXIAL SKELETAL DEFECTS; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; BONE LOSS; POSTMENOPAUSAL OSTEOPOROSIS; OSTEOBLAST DIFFERENTIATION; ANTISENSE OLIGONUCLEOTIDES;
D O I
10.1016/j.prp.2024.155413
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: Osteoclasts, which are responsible for bone resorption, are specialized multinucleated cells generated from monocyte/macrophage progenitor cells or hematopoietic stem cells (HSCs). Physiological bone remodeling can become pathological, such as osteoporosis, when osteoclastogenesis is out of balance. Thousands of long noncoding RNAs (lncRNAs) influence important molecular and biological processes. Recent research has revealed gene expression regulation function that numerous lncRNAs regulate nuclear domain organization, genome stability. Furthermore, the research of lncRNAs has substantial clinical implications for the treatment of existing and new diseases. Areas covered: In this review, we gather the most recent research on lncRNAs and their potential for basic research and clinical applications in osteoclast and osteoporosis. We also discuss the findings here in order to fully understand the role of lncRNAs in osteoclast differentiation and osteoporosis, as well as to provide a solid basis for future research exploring associated mechanisms and treatments. Expert opinion: LncRNA has been considered as an important role in the regulation of osteoclast differentiation and osteoporosis. It is exciting to investigate pathophysiological processes in osteoporosis and the therapeutic potential of lncRNAs. We hope that this review will offer promising prospects for the development of precision and individualized approaches to treatment.
引用
收藏
页数:12
相关论文
共 158 条
  • [1] p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity
    Adriaens, Carmen
    Standaert, Laura
    Barra, Jasmine
    latil, MathilDe
    Verfaillie, Annelien
    Kalev, Peter
    Boeckx, Bram
    Wijnhoven, Paul W. G.
    Radaelli, Enrico
    Vermi, William
    Leucci, Eleonora
    Lapouge, Gaelle
    Beck, Benjamin
    van den Oord, Joost
    Nakagawa, Shinichi
    Hirose, Tetsuro
    Sablina, Anna A.
    Lambrechts, Diether
    Aerts, Stein
    Blanpain, Cedric
    Marine, Jean-Christophe
    [J]. NATURE MEDICINE, 2016, 22 (08) : 861 - +
  • [2] Regulation of Osteoclast Differentiation by Cytokine Networks
    Amarasekara, Dulshara Sachini
    Yun, Hyeongseok
    Kim, Sumi
    Lee, Nari
    Kim, Hyunjong
    Rho, Jaerang
    [J]. IMMUNE NETWORK, 2018, 18 (01)
  • [3] A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance
    Anderson, Douglas M.
    Anderson, Kelly M.
    Chang, Chi-Lun
    Makarewich, Catherine A.
    Nelson, Benjamin R.
    McAnally, John R.
    Kasaragod, Prasad
    Shelton, John M.
    Liou, Jen
    Bassel-Duby, Rhonda
    Olson, Eric N.
    [J]. CELL, 2015, 160 (04) : 595 - 606
  • [4] From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights
    Anesi, Alexandre
    Generali, Luigi
    Sandoni, Laura
    Pozzi, Samantha
    Grande, Alexis
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [5] IL-8 and MCP-1 induced by excessive orthodontic force mediates odontoclastogenesis in periodontal tissues
    Asano, M.
    Yamaguchi, M.
    Nakajima, R.
    Fujita, S.
    Utsunomiya, T.
    Yamamoto, H.
    Kasai, K.
    [J]. ORAL DISEASES, 2011, 17 (05) : 489 - 498
  • [6] Denosumab and bisphosphonates: Different mechanisms of action and effects
    Baron, Roland
    Ferrari, Serge
    Russell, R. Graham G.
    [J]. BONE, 2011, 48 (04) : 677 - 692
  • [7] Class II and IV HDACs function as inhibitors of osteoclast differentiation
    Blixt, Nicholas C.
    Faulkner, Bora K.
    Astleford, Kristina
    Lelich, Rosemary
    Schering, Jacob
    Spencer, Ekaterina
    Gopalakrishnan, Rajaram
    Jensen, Eric D.
    Mansky, Kim C.
    [J]. PLOS ONE, 2017, 12 (09):
  • [8] The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
    Boyle, D. L.
    Soma, K.
    Hodge, J.
    Kavanaugh, A.
    Mandel, D.
    Mease, P.
    Shurmur, R.
    Singhal, A. K.
    Wei, N.
    Rosengren, S.
    Kaplan, I.
    Krishnaswami, S.
    Luo, Z.
    Bradley, J.
    Firestein, G. S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1311 - 1316
  • [9] Osteoclast differentiation and activation
    Boyle, WJ
    Simonet, WS
    Lacey, DL
    [J]. NATURE, 2003, 423 (6937) : 337 - 342
  • [10] HISTONE DEACETYLASES IN BONE DEVELOPMENT AND SKELETAL DISORDERS
    Bradley, Elizabeth W.
    Carpio, Lomeli R.
    van Wijnen, Andre J.
    McGee-Lawrence, Meghan E.
    Westendorf, Jennifer J.
    [J]. PHYSIOLOGICAL REVIEWS, 2015, 95 (04) : 1359 - 1381